|
1
|
Trabulo D, Ribeiro S, Martins C, Teixeira
C, Cardoso C, Mangualde J, Freire R, Gamito É, Alves AL, Augusto F,
et al: Metabolic syndrome and colorectal neoplasms: An ominous
association. World J Gastroenterol. 21:5320–5327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fancher TT, Palesty JA, Rashidi L and
Dudrick SJ: Is gender related to the stage of colorectal cancer at
initial presentation in young patients? J Surg Res. 165:15–18.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fidler IJ: Selection of successive tumour
lines for metastasis. Nat New Biol. 242:148–149. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gravekamp C, Sypniewska R, Gauntt S,
Tarango M, Price P and Reddick R: Behavior of metastatic and
nonmetastatic breast tumors in old mice. Exp Biol Med. 229:665–675.
2004. View Article : Google Scholar
|
|
5
|
Raz A, Hanna N and Fidler IJ: In vivo
isolation of a metastatic tumor cell variant involving selective
and nonadaptive processes. J Natl Cancer Inst. 66:183–189.
1981.PubMed/NCBI
|
|
6
|
Rashidi B, Gamagami R, Sasson A, Sun FX,
Geller J, Moossa AR and Hoffman RM: An orthotopic mouse model of
remetastasis of human colon cancer liver metastasis. Clin Cancer
Res. 6:2556–2561. 2000.PubMed/NCBI
|
|
7
|
Vakiani E, Janakiraman M, Shen R, Sinha R,
Zeng Z, Shia J, Cercek A, Kemeny N, D'Angelica M, Viale A, et al:
Comparative genomic analysis of primary versus metastatic
colorectal carcinomas. J Clin Oncol. 30:2956–2962. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rapti SM, Kontos CK, Papadopoulos IN and
Scorilas A: High miR-96 levels in colorectal adenocarcinoma predict
poor prognosis, particularly in patients without distant metastasis
at the time of initial diagnosis. Tumour Biol. 37:11815–11824.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hinoue T, Weisenberger DJ, Lange CP, Shen
H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk
CM, et al: Genome-scale analysis of aberrant DNA methylation in
colorectal cancer. Genome Res. 22:271–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan HT, Wu W, Ng YZ, Zhang X, Yan B, Ong
CW, Tan S, Salto-Tellez M, Hooi SC and Chung MC: Proteomic analysis
of colorectal cancer metastasis: Stathmin-1 revealed as a player in
cancer cell migration and prognostic marker. J Proteome Res.
11:1433–1445. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li G, Wang Z, Xu J, Wu H, Cai S and He Y:
The prognostic value of lactate dehydrogenase levels in colorectal
cancer: A meta-analysis. BMC Cancer. 16:2492016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tan GS, Lim KH, Tan HT, Khoo ML, Tan SH,
Toh HC and Ching Ming Chung M: Novel proteomic biomarker panel for
prediction of aggressive metastatic hepatocellular carcinoma
relapse in surgically resectable patients. J Proteome Res.
13:4833–4846. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ong SE, Blagoev B, Kratchmarova I,
Kristensen DB, Steen H, Pandey A and Mann M: Stable isotope
labeling by amino acids in cell culture, SILAC, as a simple and
accurate approach to expression proteomics. Mol Cell Proteomics.
1:376–386. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chahrour O, Cobice D and Malone J: Stable
isotope labelling methods in mass spectrometry-based quantitative
proteomics. J Pharm Biomed Anal. 113:2–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu J, Tan M and Cai Q: The warburg effect
in tumor progression: Mitochondrial oxidative metabolism as an
anti-metastasis mechanism. Cancer Lett. 356:156–164. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals. 8th. National Academies Press (US); Washington (DC):
2011
|
|
17
|
Solaun MS, Mendoza L, De Luca M, Gutierrez
V, López MP, Olaso E, Lee Sim BK and Vidal-Vanaclocha F: Endostatin
inhibits murine colon carcinoma sinusoidal-type metastases by
preferential targeting of hepatic sinusoidal endothelium.
Hepatology. 35:1104–1116. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Osinalde N, Sánchez-Quiles V, Akimov V,
Blagoev B and Kratchmarova I: SILAC-based quantification of changes
in protein tyrosine phosphorylation induced by interleukin-2 (IL-2)
and IL-15 in T-lymphocytes. Data Brief. 5:53–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Osinalde N, Mitxelena J, Sánchez-Quiles V,
Akimov V, Aloria K, Arizmendi JM, Zubiaga AM, Blagoev B and
Kratchmarova I: Nuclear phosphoproteomic screen uncovers ACLY as
mediator of IL-2-induced proliferation of CD4+ T
lymphocytes. Mol Cell Proteomics. 15:2076–2092. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Qiao B, Zhao T, Hu F, Lam AK and
Tao Q: Sox2 promotes tumor aggressiveness and epithelialmesenchymal
transition in tongue squamous cell carcinoma. Int J Mol Med.
42:1418–1426. 2018.PubMed/NCBI
|
|
21
|
Hieda M, Matsuura N and Kimura H: Histone
modifications associated with cancer cell migration and invasion.
Methods Mol Biol. 1238:301–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Worley MJ Jr, Liu S, Hua Y, Kwok JS,
Samuel A, Hou L, Shoni M, Lu S, Sandberg EM, Keryan A, et al:
Molecular changes in endometriosis-associated ovarian clear cell
carcinoma. Eur J Cancer. 51:1831–1842. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lim W, Ryu S, Bazer FW, Kim SM and Song G:
Chrysin attenuates progression of ovarian cancer cells by
regulating signaling cascades and mitochondrial dysfunction. J Cell
Physiol. 233:3129–3140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boland ML, Chourasia AH and Macleod KF:
Mitochondrial dysfunction in cancer. Front Oncol. 3:2922013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ishikawa K, Takenaga K, Akimoto M,
Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y and Hayashi
J: ROS-generating mitochondrial DNA mutations can regulate tumor
cell metastasis. Science. 320:661–664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ishikawa K, Koshikawa N, Takenaga K,
Nakada K and Hayashi J: Reversible regulation of metastasis by
ROS-generating mtDNA mutations. Mitochondrion. 8:339–344. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Esposito LA, Melov S, Panov A, Cottrell BA
and Wallace DC: Mitochondrial disease in mouse results in increased
oxidative stress. Proc Natl Acad Sci USA. 96:4820–4825. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chazotte B: Labeling mitochondria with
TMRM or TMRE. Cold Spring Harb Protoc. 2011:895–897. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wood S Jr: Mechanisms of establishment of
tumor metastases. Pathobiol Annu. 1:281–308. 1971.PubMed/NCBI
|
|
30
|
Vaiopoulos AG, Athanasoula KCh and
Papavassiliou AG: Epigenetic modifications in colorectal cancer:
Molecular insights and therapeutic challenges. Biochim Biophys
Acta. 1842:971–980. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen S and Chiu SK: AP4 activates cell
migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma
cells. Mol Cell Biochem. 407:57–68. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bae WK, Yoo KH, Lee JS, Kim Y, Chung IJ,
Park MH, Yoon JH, Furth PA and Hennighausen L: The
methyltransferase EZH2 is not required for mammary cancer
development, although high EZH2 and low H3K27me3 correlate with
poor prognosis of ER-positive breast cancers. Mol Carcinog.
54:1172–1180. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoo KH and Hennighausen L: EZH2
methyltransferase and H3K27 methylation in breast cancer. Int J
Biol Sci. 8:59–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ngo DC, Ververis K, Tortorella SM and
Karagiannis TC: Introduction to the molecular basis of cancer
metabolism and the warburg effect. Mol Biol Rep. 42:819–823. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pelicano H, Xu RH, Du M, Feng L, Sasaki R,
Carew JS, Hu Y, Ramdas L, Hu L, Keating MJ, et al: Mitochondrial
respiration defects in cancer cells cause activation of akt
survival pathway through a redox-mediated mechanism. J Cell Biol.
175:913–923. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Justus CR, Sanderlin EJ and Yang LV:
Molecular connections between cancer cell metabolism and the tumor
microenvironment. Int J Mol Sci. 16:11055–11086. 2015. View Article : Google Scholar : PubMed/NCBI
|
